WE DEVELOP, MANUFACTURE AND MARKET NON-INVASIVE CANCER TESTS USING OUR UNIQUE TECHNOLOGY, PARTNERING WITH LEADING CENTERS AROUND THE WORLD

Nucleix’s Bladder EpiCheck® Receives FDA 510(k) Clearance for Monitoring of Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence

Bladder EpiCheck®

Bladder EpiCheck®, CE-marked and available in Europe for primary and recurrent bladder cancer and upper tract urinary cancer, and FDA 510(k) cleared for bladder cancer recurrence in the United States.

bladder-epicheck Bladder Page
bladder-epicheck
Lung EpiCheck®

In development

Detect early stage lung cancer in high-risk individuals with a simple blood test

lung-epicheck Lung Page
lung-epicheck
EpiCheck Pipeline

Nucleix R&D has the capabilities and experience to develop additional liquid biopsy assays for other types of cancer

EpiCheck-PipelineMobileImg
EpiCheck-Pipeline-Img

EPICHECK IS A PLATFORM TECHNOLOGY

DELIVERING HIGHLY ACCURATE AND SENSITIVE RESULTS WITH A SEAMLESS TESTING OPTION FOR PATIENTS AND THE HEALTHCARE SYSTEM

Technology Page

COLLABORATIONS

We are working with leading medical centers, organizations and laboratories worldwide

  • 1_cleveland
    Cleveland
    Clinic

  • radbound
    Radboud
    UMC
  • duke
    Duke
    Hospital
  • synlab
    Synlab
  • washington
    University of
    Washington
  • ers
    Fundacio
    Puigvert
  • amc
    AMC
  • tor vergata
    Tor Vergata
  • la paz
    Hospital
    La Paz
  • meir
    Meir Medical
    Center
  • vanderbilt
    Vanderbilt
    University
  • vall d'herbron
    Vall d'Hebron
  • vall d'herbron
    Gemelli
    Hospital Clinic
  • Group 1785
    AML Israel
    American Medical Laboratories
  • Group 1787
    Hospital Clinic Barcelona
  • Group 1786
    University of Padua
  • Logo2-Osakidetza-Hospital-Universitario-Donostia75
    Hospital Universitario Donostia
  • Aarhus
    Aarhus University Hospital
  • Snquin
    Sanquin
  • Sourasky
    Tel Aviv Sourasky Medical Center
  • UHN
    UHN
  • Sheba
    Sheba Medical Center
  • ZGT
    ZGT
  • Untitled 1
    Bolzano Hpt
  • Untitled2
    Tor Vergata Hpt
  • Untitled3
    Orbassano Hpt

SOCIAL MEDIA

Subscribe to one of our social media channels

close

Subscription Confirmation Required

Go to your email inbox

Go to your email inbox

Go to the inbox of the email
address you just used to sign up.

Open the confirmation email

Open the confirmation email

Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “[email protected]”.

Click the confirmation link

Click the confirmation link

Click on the link inside the
email and you’re good to go.

GOT IT !